Zenas Biopharma, Inc IPOs Tomorrow, Here's What You Need To Know
Zenas Biopharma, Inc IPOs Tomorrow, Here's What You Need To Know
Zenas BioPharma, Inc is a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative immunology-based therapies for patients in need.Zenas BioPharma, Inc (NASDAQ:ZBIO) IPO will take place September, 13 on the NASDAQ exchange under the ticker ZBIO.
Zenas BioPharma, Inc（納斯達克股票代碼：ZBIO）的首次公開發行（IPO）將於9月13日在納斯達克交易所進行，交易代碼爲ZBIO。
The company is offering shares at an expected price between $16.00 and $18.00 per share with an insider lock-up period of 180 days ending on March 12, 2025.
該公司以每股16.00美元至18.00美元的預期價格出售股票，內部鎖定期爲180天，截止日期爲2025年3月12日。
See also: Benzinga IPO Calendar
參見：Benzinga IPO日曆
About Zenas BioPharma, Inc
關於Zenas BioPharma, Inc
Zenas BioPharma, Inc is a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative immunology-based therapies for patients in need.
Zenas BioPharma, Inc是一家全球處於臨床階段的生物製藥公司，致力於成爲免疫學爲基礎的變革性治療方案開發和商業化的領導者，以滿足有需要的患者的需求。
See also: Benzinga's Most Shorted Stocks
參見：Benzinga的做空集合股
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自動化內容引擎生成並由編輯審查。